Tower Research Capital (TRC)’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-500
| Closed | -$5K | – | 4651 |
|
|
2018
Q4 | $5K | Buy |
500
+405
| +426% | +$4.05K | ﹤0.01% | 2978 |
|
|
2018
Q3 | $2K | Sell |
95
-7,959
| -99% | -$168K | ﹤0.01% | 3525 |
|
|
2018
Q2 | $128K | Buy |
+8,054
| New | +$128K | 0.01% | 1287 |
|
|
2018
Q1 | – | Sell |
-1,958
| Closed | -$22K | – | 4251 |
|
|
2017
Q4 | $22K | Buy |
+1,958
| New | +$22K | ﹤0.01% | 2005 |
|
|
2017
Q1 | – | Sell |
-4,227
| Closed | -$88K | – | 4350 |
|
|
2016
Q4 | $88K | Buy |
4,227
+4,218
| +46,867% | +$87.8K | 0.01% | 1046 |
|
|
2016
Q3 | $0 | Buy |
+9
| New | – | ﹤0.01% | 4911 |
|
|
2016
Q2 | – | Sell |
-2,434
| Closed | -$60K | – | 5302 |
|
|
2016
Q1 | $60K | Buy |
2,434
+2,122
| +680% | +$52.3K | 0.01% | 691 |
|
|
2015
Q4 | $10K | Buy |
312
+135
| +76% | +$4.33K | ﹤0.01% | 2187 |
|
|
2015
Q3 | $6K | Sell |
177
-794
| -82% | -$26.9K | ﹤0.01% | 2720 |
|
|
2015
Q2 | $51K | Sell |
971
-994
| -51% | -$52.2K | ﹤0.01% | 1359 |
|
|
2015
Q1 | $57K | Buy |
1,965
+1,232
| +168% | +$35.7K | 0.01% | 1371 |
|
|
2014
Q4 | $21K | Buy |
+733
| New | +$21K | ﹤0.01% | 1577 |
|
|
2014
Q3 | – | Sell |
-6,058
| Closed | -$122K | – | 5139 |
|
|
2014
Q2 | $122K | Buy |
+6,058
| New | +$122K | 0.02% | 798 |
|